Fungal infections are spreading and climate change is to blame
A world taken over by fungal infections, with no vaccine available: It sounds like the plot of post-apocalyptic show The Last of Us, but it could become our reality as climate change makes diseases caused by fungi, like valley fever, better at spreading. Valley fever is usually only contracted in…#valley #arizona #cdc #bridgetbarker #coccidioides #rebeccadrummond #drummond #geohealth #greatplains #centralamerica (Source: Reuters: Health)
Source: Reuters: Health - February 3, 2023 Category: Consumer Health News Source Type: news

Survivors of deadly fungal infection Valley fever share their horror stories with DM.com
Nick Duggan, 45, is one of around 20,000 people who catch the illness - caused by fungi species Coccidioidomycosis - every year, which scientists warn is becoming more common. (Source: the Mail online | Health)
Source: the Mail online | Health - February 3, 2023 Category: Consumer Health News Source Type: news

Janssen Announces Unblinding of Phase 3 CARTITUDE-4 Study of CARVYKTI ® (cilta-cel) as Primary Endpoint Met in Treatment of Patients with Relapsed and Refractory Multiple Myeloma
RARITAN, New Jersey, January 27, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) versus pomalidomide, bortezomib, and dexamethasone (PVd) or daratumumab, pomalidomide, and dexamethasone (DPd) for the treatment of patients with relapsed and lenalidomide-refractory multiple myeloma met its primary endpoint of significant improvement in progression-free survival (PFS) at the first pre-specified interim analysis. As a result of meeting the primary endpoint, the Independent Data Monitoring Commi...
Source: Johnson and Johnson - January 27, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

‘The Last of Us’ recap: More ground rules and a big dose of body horror
Measured against the intro to the first episode — the talk show bit — I thought this was much stronger. The first intro had the unenviable job of having to explain the idea of an apocalyptic fungal infection to an audience that may have been primed for just another zombie TV show. Here, we know…#ratna #tess #ellies #statehouse #lastofus (Source: Reuters: Health)
Source: Reuters: Health - January 23, 2023 Category: Consumer Health News Source Type: news

‘The Last Of Us’ Zombie Infection Is Real—Here’s What Scientists Say About The Threat To Humans
The zombifying fungal infection that wiped out humanity in The Last of Us is based on a very real set of parasitic fungi that hijack insects and compel them to pass the infection on. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 16, 2023 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Games /games Hollywood & Entertainment /hollywood-entertainment Healthcare /healthcare Science /science Breaking breaking-news Source Type: news

Stomatitis Risk With Everolimus Reduced by Slow Dose Escalation Stomatitis Risk With Everolimus Reduced by Slow Dose Escalation
Going slow with everolimus reduces the risk of mouth ulcers and offers an alternative to steroid mouthwashes and their risk of oral fungal infections, say German researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

F2G Announces FDA Filing Acceptance Of New Drug Application For Olorofim For The Treatment Of Invasive Fungal Infections
PRINCETON, N.J., Dec. 19, 2022 (GLOBE NEWSWIRE) -- F2G Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for olorofim for the treatment of invasive fungal infections in... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 19, 2022 Category: Drugs & Pharmacology Source Type: news

Dr. B. Dental Solutions Simplifies the Care of Dentures and Oral Appliances with the Launch of Two New Products
Dallas, Texas, Oct 19, 2022 (Newsfile Corp via COMTEX) -- Dallas, Texas--(Newsfile Corp. - October 19, 2022) - Dr. B Dental Solutions has announced the launch of two new products for people with dentures, implant retained or supported dentures, and removable dental appliances. The two products - the Liquid Crystal disinfectant soak cleanser and UltraSonic cleaner, have been specifically designed to optimize health and simplify the care of dentures and dental appliances. The Liquid Crystal Soak Cleanser from Dr. B ' s Dental Solutions is the only cleanser that fully disinfects disease-causing bacteria and fungi. It kills 99...
Source: Dental Technology Blog - December 13, 2022 Category: Dentistry Source Type: news

Former Vice President and General Manager of New England Compounding Center Sentenced to Prison
FDA OCI, Gregory Conigliaro, Southborough, Mass, sentence, defraud, FDA, Vice President, General Manager, NECC, New England Compounding Center, shipping, Rx drugs, bulk, decade, evade, regulatory oversight, fraud, health care, prison, patient-specific, cGMP, fungal, infection, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - December 2, 2022 Category: Medical Law Authors: DOJ Source Type: news

Climate Change May Bring More Fungal Lung Infections
MONDAY, Nov. 28, 2022 -- Fungal lung infections are spreading to parts of the United States where they were once never seen— likely a result of climate change, experts say. To the average person, the term fungal infection may conjure up... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 28, 2022 Category: General Medicine Source Type: news

Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news

Emerging Invasive Fungal Infections Call for Better Records Emerging Invasive Fungal Infections Call for Better Records
Emerging invasive fungal infections present a new diagnostic and therapeutic challenge and a growing concern for immunocompromised patients, said a mycologist.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 7, 2022 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news

CDC Characterizes National Incidence of Fungal Infections
THURSDAY, Aug. 18, 2022 -- Coccidioidomycosis, histoplasmosis, and blastomycosis cause substantial illness, with about 20,000 cases of coccidioidomycosis reported in 2019, according to research published in the Aug. 19 issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 18, 2022 Category: Pharmaceuticals Source Type: news

How to Return to Normal After Having Your Bladder Surgically Removed
When Jodi Byfuglin, 56, was diagnosed with bladder cancer, it felt like cruel irony. Byfuglin had lost both her parents to cancer in their 50s, and as a single mother of two, she was all her kids had left. “I promised that I would not leave them,” Byfuglin says. Bladder cancer is the sixth most common cancer in the United States, and older men are at highest risk. But about one-tenth of cases are in people younger than 55, and an estimated 19,480 women will be diagnosed with bladder cancer in 2022 (compared to about 61,700 men), according to the American Cancer Society. “I had no idea about bladder cancer...
Source: TIME: Health - July 28, 2022 Category: Consumer Health News Authors: Simar Bajaj Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news